Measurement | Definition |
---|---|
Rheumatoid arthritis | |
   Swollen joint count (SJC) | Number of swollen joints as determined by the physician out of a standard set of 28 joints |
   Tender joint count (TJC) | Number of joints tender to palpation (as for SJC) |
   Patient assessment of pain | Measured by 100 mm visual analog scale (VAS) |
   Patient assessment of global disease activity | Measured by 100 mm VAS |
   Physician assessment of global disease activity | Measured on a six-point scale ranging from 'no activity' to 'maximum activity' |
   Acute phase reactant | ESR (mm/h) and/or CRP (mg/l) |
   Health Assessment questionnaire (HAQ) | Assessment of functional status (0 to 3 points) |
   EuroQol five dimensions utility score (EQ-5D) | Assessment of health-related quality of life (HRQOL) (0 to 1) |
   Disease Activity Score (DAS28) | Assessment of disease activity computed using SJC, TJC, ESR and patient assessment of global disease activity, based on 28 joints. Termed DAS28-CRP when CRP is used instead of ESR |
Inflammatory bowel disease | |
   Hemoglobin level | Measure in g/l |
   Acute phase reactant | ESR (mm/h) and/or CRP (mg/l) |
   Harvey Bradshaw Index (HBI) | Assessment of disease activity completed by both patient and physician |
   Short Health Scale (SHS) | Assessment of HRQOL in four domains, measured by 100 mm VAS |
Psoriasis | |
   Psoriasis Area and Severity Index (PASI) | Assessment of extent and severity of skin lesions consisting of four components; scaling, redness, extent and elevation (0 to 72 points) |
   Dermatology Life Quality Index (DLQI) | Assessment of the effect of skin disease on HRQOL (0 to 30 points) |